Studies with T2DM patients have shown that only TNFR1 and TNFR2 receptors are associated with a risk of end-stage renal disease, wherein elevated serum levels of TNFR1 are associated with DN [34] and decreased renal function [35, 36]. This evidence concerns the gene TNFRSF1A and liver dysplastic nodule.